FFO
CABA icon

Fortitude Family Office’s Cabaletta Bio CABA Stock Holding History

Fortitude Family Office’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-163
Closed -$438 – 2282
2026
Q1 		$438 Buy
+163
New +$453 ﹤0.01% 1775
2024
Q2 		– Sell
-262
Closed -$4.47K – 980
2024
Q1 		$4.47K Hold
262
– – ﹤0.01% 656
2023
Q4 		$5.95K Buy
+262
New +$4.41K ﹤0.01% 535

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Fortitude Family Office's CABA Position: Q2 2026 in Review

Fortitude Family Office sold out of Cabaletta Bio (CABA) in Q2 2026, closing a stake of 163 shares — an estimated $438 sold.

Fortitude Family Office first reported a position in CABA in Q4 2023 and held it in 3 quarters. The position peaked at $5.95K in Q4 2023. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Fortitude Family Office reported no remaining Cabaletta Bio position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 163 Cabaletta Bio shares in Q2 2026, an estimated $438.
  • Fortitude Family Office first reported a position in Cabaletta Bio in Q4 2023 and held it in 3 quarters.
  • Fortitude Family Office's Cabaletta Bio position peaked at $5.95K in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.